There is evidence that implicates ELOVL5 (61), DHCR7 (71), ACOT7 (72), ME1 (73), ACACB (74), FASN (75), ACSL6 (76), CPT1B (77), FAAH (78), ANGPTL4 (79), STARD3 (80), SRD5A1 (81), HSD171B (82), NCOA1 (83), UGT8 (40), INPP4B (84), DGAT2 (85), MBOAT1 (86), PTGR1 (87), and PLD6 (88) in breast cancer prognosis. Here, NCOA1 is linked to breast carcinoma.